Halozyme Therapeutics
HALO
#2058
Rank
A$12.03 B
Marketcap
$97.76
Share price
0.75%
Change (1 day)
57.18%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : A$2.39 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is A$2.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$2.42 B10.01%
2023-12-31A$2.20 B-0.57%
2022-12-31A$2.21 B83.03%
2021-12-31A$1.20 B134.08%
2020-12-31A$0.51 B-10.16%
2019-12-31A$0.57 B220.52%
2018-12-31A$0.17 B-30.79%
2017-12-31A$0.25 B-13.75%
2016-12-31A$0.30 B339.32%
2015-12-31A$68.4 M12.28%
2014-12-31A$60.92 M9.18%
2013-12-31A$55.79 M86.38%
2012-12-31A$29.93 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$75.89 M-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$53.53 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.39 B 793.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$101.27 B 4,126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.64 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
A$58.28 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA